NET PROFIT (x1000 NOK)
EMPLOYEES
Wilson Therapeutics AB
Closing information (x1000 NOK)
| Closing information | 2020/12 | 2019/12 | 2018/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
922,905
|
2,140
|
3,289 |
| Earnings before taxes |
-709,953
|
6,370,338
|
-381,789 |
| EBITDA |
-876
|
6,293,936
|
-392,483 |
| Total assets |
6,748,246
|
12,300,830
|
78,802 |
| Current assets |
6,748,141
|
12,299,444
|
13,966 |
| Current liabilities |
70,248
|
5,634,459
|
43,593 |
| Equity capital |
6,677,998
|
6,666,372
|
35,080 |
| - share capital |
3,294
|
2,972
|
3,069 |
| Employees (average) |
0
|
1
|
14 |
Financial ratios
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Solvency |
99.0%
|
54.2%
|
44.5% |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
3.2%
|
51.8%
|
-480.3% |
| Current ratio |
9606.2%
|
218.3%
|
32.0% |
| Return on equity (ROE) |
-10.6%
|
95.6%
|
-1088.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-13
|
0 |
| Chg. No. of employees % |
-100%
|
-93% |
Total value of public sale
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.